Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POMALYST Cause Chronic obstructive pulmonary disease? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Chronic obstructive pulmonary disease have been filed in association with POMALYST. This represents 0.6% of all adverse event reports for POMALYST.

8
Reports of Chronic obstructive pulmonary disease with POMALYST
0.6%
of all POMALYST reports
2
Deaths
5
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From POMALYST?

Of the 8 reports, 2 (25.0%) resulted in death, 5 (62.5%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for POMALYST. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does POMALYST Cause?

Death (177) Plasma cell myeloma (162) Pneumonia (98) Fatigue (94) Full blood count decreased (51) Dyspnoea (47) Dizziness (38) Neuropathy peripheral (37) Rash (36) Asthenia (35)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which POMALYST Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

POMALYST vs PONATINIB POMALYST vs PONATINIB\PONATINIB POMALYST vs PONESIMOD POMALYST vs PORACTANT ALFA POMALYST vs PORFIMER

Related Pages

POMALYST Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease POMALYST Demographics